DE69903037D1 - Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren - Google Patents

Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren

Info

Publication number
DE69903037D1
DE69903037D1 DE69903037T DE69903037T DE69903037D1 DE 69903037 D1 DE69903037 D1 DE 69903037D1 DE 69903037 T DE69903037 T DE 69903037T DE 69903037 T DE69903037 T DE 69903037T DE 69903037 D1 DE69903037 D1 DE 69903037D1
Authority
DE
Germany
Prior art keywords
human growth
component
growth factors
angiogenic agent
agent together
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69903037T
Other languages
English (en)
Other versions
DE69903037T2 (de
Inventor
Marina Ziche
Silvia Donini
Francesco Borrelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of DE69903037D1 publication Critical patent/DE69903037D1/de
Publication of DE69903037T2 publication Critical patent/DE69903037T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69903037T 1998-07-09 1999-07-02 Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren Expired - Lifetime DE69903037T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98112775 1998-07-09
PCT/EP1999/004605 WO2000002579A2 (en) 1998-07-09 1999-07-02 Component b as angiogenic agent in combination with human growth factors

Publications (2)

Publication Number Publication Date
DE69903037D1 true DE69903037D1 (de) 2002-10-24
DE69903037T2 DE69903037T2 (de) 2003-06-05

Family

ID=8232248

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69903037T Expired - Lifetime DE69903037T2 (de) 1998-07-09 1999-07-02 Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren

Country Status (12)

Country Link
US (2) US6855684B2 (de)
EP (1) EP1093380B1 (de)
JP (1) JP2002520292A (de)
AT (1) ATE224200T1 (de)
AU (1) AU765600B2 (de)
CA (1) CA2336773C (de)
DE (1) DE69903037T2 (de)
DK (1) DK1093380T3 (de)
ES (1) ES2184480T3 (de)
IL (2) IL140778A0 (de)
PT (1) PT1093380E (de)
WO (1) WO2000002579A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140778A0 (en) * 1998-07-09 2002-02-10 Applied Research Systems Pharmaceutical compositions comprising component b and a human growth factor
WO2002022176A1 (en) 2000-09-15 2002-03-21 Genvec, Inc. Method of modulating neovascularization
JP4891065B2 (ja) * 2003-04-16 2012-03-07 メルク セローノ ソシエテ アノニム Ｓｌｕｒｐ−１組成物及びその使用方法
US20060128939A1 (en) * 2004-12-03 2006-06-15 Vijayendra Kumar One pot process for making polymeric antioxidants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
ATE234110T1 (de) * 1996-04-24 2003-03-15 Applied Research Systems Komponente b als wundheilendes mittel
IL140778A0 (en) * 1998-07-09 2002-02-10 Applied Research Systems Pharmaceutical compositions comprising component b and a human growth factor

Also Published As

Publication number Publication date
ES2184480T3 (es) 2003-04-01
DE69903037T2 (de) 2003-06-05
EP1093380A2 (de) 2001-04-25
JP2002520292A (ja) 2002-07-09
AU765600B2 (en) 2003-09-25
CA2336773C (en) 2009-12-15
DK1093380T3 (da) 2003-01-27
WO2000002579A3 (en) 2000-02-24
US20050153892A1 (en) 2005-07-14
US20010031733A1 (en) 2001-10-18
WO2000002579A2 (en) 2000-01-20
CA2336773A1 (en) 2000-01-20
US7223732B2 (en) 2007-05-29
PT1093380E (pt) 2003-01-31
IL140778A (en) 2008-03-20
IL140778A0 (en) 2002-02-10
AU5030699A (en) 2000-02-01
US6855684B2 (en) 2005-02-15
ATE224200T1 (de) 2002-10-15
EP1093380B1 (de) 2002-09-18

Similar Documents

Publication Publication Date Title
AR003123A1 (es) Una composicion sinergica de por lo menos un compuesto de actividad antimicrobiana y de por lo menos un monoalquileter de glicerol y utilizacionesde los mismos como agentes antimicrobianos en una composicion cosmetica o farmaceutica como asi tambien en la preparacion de composiciones farmaceuticas
DE69313126T2 (de) Mundwasserkonzentrat zur wirksamen abgabe antimikrobieller mittel
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
TR200003635T2 (tr) Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması.
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
NO865079D0 (no) Stabiliserte humanvev-plaminogenaktivator-preparater.
DE69921318D1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
DK1235571T3 (da) Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type
DK1059934T3 (da) Matrixproteinpræparater til sårheling
PT1112083E (pt) Uso de um factor angiogenico para o tratamento de angiopatias microvasculares
DK1089704T3 (da) Hårplejelotion til topisk anvendelse
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
DK0639373T3 (da) Præparater til udvortes påføring af antiseptiske midler og/eller midler der fremmer sårheling
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
AR020455A1 (es) Composicion insecticida
PT1175433E (pt) Glicosidos androgenos e sua actividade androgenica
DE69903037T2 (de) Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren
IT1267429B1 (it) Cannula per trattamenti di liposuzione e manipolo utilizzante tale cannula
NO984760D0 (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
IS6581A (is) Samsetning sem eykur hreyfanleika
BR9301375A (pt) Composicao cosmetica
DE59915118D1 (de) Stabile zubereitungen mit hyperforin
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
DE60120159D1 (de) Hautpflegemittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH